On the other hand, TLR7 preconditioning [i.e., pre-treatment with a TLR7 agonist, gardiquimod (GDQ), prior to ischemia] has shown protection against subsequent stroke injury through type I IFN-mediated mechanism (Leung et al., 2012). The gene discussed is TLR7; the disease is stroke disorder.